Has Aaron Kusano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,764 in general payments to Aaron Kusano, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aaron Kusano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aaron Kusano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aaron Kusano, MD

Radiation Oncology · Anchorage, AKNPI 1407170467

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,084 of the $1,764 with a category attached, or 61.5%. Siemens Medical Solutions USA, Inc. accounts for 66.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $1,188 and has fallen 98.8% since, to $14 in 2025.

$1,764in general payments, 2019–2025

Across 20 payments — averaging $88.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Siemens Medical Solutions USA, Inc.$1K
Boston Scientific$178
AstraZeneca$167
Elekta, Inc.$143
E.r. Squibb & Sons, L.L.C.$81
Myriad Genetic Laboratories, Inc.$20

What the payments were for

Travel & lodging$1,08461%
Food & beverage$68039%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Siemens Medical Solutions USA, Inc.	7	$1,175
Boston Scientific	4	$178
AstraZeneca	4	$167
Elekta, Inc.	3	$143
E.r. Squibb & Sons, L.L.C.	1	$81
Myriad Genetic Laboratories, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few radiation oncology providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$368,413

Medicare patients

326

Services billed

2,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	43	$1,146

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Anchorage

William MagnusonAnchorage$2K
John HalliganAnchorage$874
Stephen SettleAnchorage$632
Larry DaughertyAnchorage$331
Daniel SeibleAnchorage$198
James BlomAnchorage$43
Ewa ZabrockaAnchorage$15
Stacey WellsSoldotna$4K
John YordyPalmer$1K
Eugene HuangJuneau$324

See the full list for Alaska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →